发明名称 Piperazinyl pyrimidine derivatives, preparation method and use thereof
摘要 Provided are piperazinyl pyrimidine derivatives of formula I having CCR4 antagonism, and the preparation method, pharmaceutical composition and use thereof in the preparation of a medicament. The medicament is useful for the treatment and prevention of CCR4-related diseases.;
申请公布号 US9493453(B2) 申请公布日期 2016.11.15
申请号 US201314372710 申请日期 2013.01.15
申请人 The Institute of Pharmacology and Toxicology Academy of Military Medical Science P.L.A. CHINA;PEKING UNIVERSITY 发明人 Li Song;Wang Ying;Xiao Junhai;Ma Dalong;Gong Hongwei;Qi Hui;Wang Lili;Ling Xiaomei;Zheng Zhibing;Zhang Yang;Zhong Wu;Li Meina;Xie Yunde;Xu Enquan;Li Xingzhou;Ma Jing;Zhao Guoming;Zhou Xinbo;Wang Xiaokui;Liu Hongying
分类号 C07D401/12;C07D417/12;A61K31/496;A61K31/541;C07D471/04;C07D403/14;C07D403/12;C07D239/50;A61K31/519 主分类号 C07D401/12
代理机构 Banner & Witcoff, Ltd. 代理人 Banner & Witcoff, Ltd.
主权项 1. A compound of formula I,wherein: any two of A, B and D are N and the other one is CH; Z is selected from the group consisting of —C(O)— and —S(O)2—; X is halogen or N, with the proviso that when X is halogen, R1 and R2 in formula I are absent; R1 and R2 are each independently selected from the group consisting of H, linear or branched alkyl having 1 to 6 carbon atoms, linear or branched heteroalkyl having 1-6 carbon atoms in which 1 to 2 of the non-terminal carbon atoms independently are replaced by O, NH, or S; R3 is H; R4 is selected from the group consisting of aryl and fused aryl containing 5 to 10 atoms; wherein said aryl or fused aryl is optionally and independently mono-, di- or poly-substituted with halogen; R5 is selected from the group consisting of linear or branched alkyl having 1 to 6 carbon atoms, linear or branched heteroalkyl having 1 to 6 carbon atoms in which 1 to 2 of the non-terminal carbon atoms independently are replaced by O, NH, or S, cycloalkyl containing 4 to 8 carbon atoms, 5- to 8-membered heterocycloalkyl containing 1 to 2 heteroatoms independently selected from the group consisting of O, N and S; m is 0, 1 or 2; and n is 1, or a racemate or a stereoisomer, or a pharmaceutically acceptable salt or solvate thereof.
地址 Beijing CN
您可能感兴趣的专利